Bayer to Invest $2.2 Billion in New U.S. Pharmaceutical Manufacturing Site

Key Facts

Bayer announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio. According to a company statement reported by Business Wire, the investment is a central element of Bayer's commitment to innovation and patient access in the United States, which remains its largest pharmaceuticals market.

The establishment of the new facility is part of Bayer AG's long-term growth strategy in the U.S. market. In equity markets, BAYRY closed at $12.73 on October 1, 2026, with the stock reaching a session high of $13.15 and a low of $12.71 during that period.